Bexagliflozin

DRUG13 trials

Sponsors

Theracos

Conditions

Essential HypertensionType 2 Diabetes MellitusType2 Diabetes Mellitus

Phase 1

Study to Evaluate the Effects of a High-Fat Meal on Bexagliflozin in Healthy Subjects

CompletedNCT02820298

TheracosType 2 Diabetes Mellitus

Start: 2016-06-20End: 2016-08-29Updated: 2021-06-10

Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin

CompletedNCT02956044

TheracosType2 Diabetes Mellitus

Start: 2016-11-30End: 2017-03-31Updated: 2021-07-22

Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection

CompletedNCT03167411

TheracosType2 Diabetes Mellitus

Start: 2017-05-24End: 2017-06-29Updated: 2021-05-28

Bexagliflozin Drug/Drug Interaction Study With Digoxin

CompletedNCT03197324

TheracosType2 Diabetes Mellitus

Start: 2017-07-24End: 2017-09-17Updated: 2021-07-23

Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects

CompletedNCT03296800

TheracosType 2 Diabetes Mellitus

Start: 2017-09-27End: 2017-12-06Updated: 2021-07-01

Absolute Bioavailability Study With Bexagliflozin

WithdrawnNCT03417076

TheracosType 2 Diabetes Mellitus

Start: 2018-08-01End: 2018-09-16Updated: 2019-09-30

Safety and Efficacy of Bexagliflozin in Subjects With Moderate Hepatic Impairment

CompletedNCT03557658

TheracosType2 Diabetes Mellitus

Start: 2018-07-26End: 2018-12-26Updated: 2021-06-03

Phase 2

An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension

CompletedNCT03514641

TheracosEssential Hypertension

Start: 2017-10-18End: 2018-11-30Updated: 2021-09-21

Phase 3

Bexagliflozin Efficacy and Safety Trial

CompletedNCT02558296

TheracosType 2 Diabetes Mellitus

Start: 2015-10-31End: 2019-10-23Updated: 2021-07-14

Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes

CompletedNCT02715258

TheracosType 2 Diabetes Mellitus

Start: 2016-03-31End: 2017-04-30Updated: 2021-06-28

Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

CompletedNCT02769481

TheracosType 2 Diabetes Mellitus

Start: 2016-08-15End: 2019-06-14Updated: 2021-05-27

Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment

CompletedNCT02836873

TheracosType 2 Diabetes Mellitus

Start: 2016-09-23End: 2018-01-11Updated: 2021-06-30

Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

CompletedNCT03115112

TheracosType 2 Diabetes Mellitus

Start: 2017-10-12End: 2018-10-31Updated: 2021-06-22